Anatomy and physiology of the blood-brain barriers

AAPS Advances in the Pharmaceutical Sciences Series

Volumn 10, Issue , 2014, Pages 3-21

  Abbott, N Joan ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; BREAST CANCER RESISTANCE PROTEIN; CELL ENZYME; CENTRAL NERVOUS SYSTEM AGENTS; CLAUDIN 1; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; DRUG TARGETING; DRUG TRANSPORT; HUMAN; INFLAMMATION; INTERSTITIAL FLUID; MICROGLIA; NEUROPIL; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; TIGHT JUNCTION; TRANSCYTOSIS; TRANSPORT AT THE CELLULAR LEVEL; ANATOMY; BLOOD VESSEL INNERVATION; CELL HETEROGENEITY; CELL SURFACE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ENDOTHELIUM; HOMEOSTASIS; PHYSIOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 85081149543     PISSN: 22107371     EISSN: 2210738X     Source Type: Book Series    
DOI: 10.1007/978-1-4614-9105-7_1     Document Type: Article

References (93)

1. Aänismaa P, Gatlik-Landwojtowicz E, Seelig A (2008) P-glycoprotein senses its substrates and the lateral membrane packing density: consequences for the catalytic cycle. Biochemistry 47:10197-10207
2. Abbott NJ (1992) Comparative physiology of the blood-brain barrier. In: Bradbury MWB (ed) Physiology and pharmacology of the blood-brain barrier, vol 103, Handb Exp Pharmacol. Springer, Heidelberg, pp 371-396
3. Abbott NJ, Mendonça LL, Dolman DE (2003) The blood-brain barrier in systemic lupus erythematosus. Lupus 12:908-915
4. Abbott NJ (2004) Evidence for bulk flow of brain interstitial fl uid: signifi cance for physiology and pathology. Neurochem Int 45:545-552
5. Abbott NJ (2013) Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36:437-449
6. Abbott NJ, Friedman A (2012) Overview and introduction: the blood-brain barrier in health and disease. Epilepsia 53 (Suppl 6):1-6
7. Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7:41-53
8. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, Begley DJ (2010) Structure and function of the blood-brain barrier. Neurobiol Dis 37:13-25
9. Alvarez JI, Dodelet-Devillers A, Kebir H, Ifergan I, Fabre PJ, Terouz S, Sabbagh M, Wosik K, Bourbonnière L, Bernard M, van Horssen J, de Vries HE, Charron F, Prat A (2011) The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 334:1727-1731
10. Armulik A, Genové G, Mäe M, Nisancioglu MH, Wallgard E, Niaudet C, He L, Norlin J, Lindblom P, Strittmatter K, Johansson BR, Betsholtz C (2010) Pericytes regulate the blood-brain barrier. Nature 468:557-561
11. Bazan NG, Eady TN, Khoutorova L, Atkins KD, Hong S, Lu Y, Zhang C, Jun B, Obenaus A, Fredman G, Zhu M, Winkler JW, Petasis NA, Serhan CN, Belayev L (2012) Novel aspirintriggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke. Exp Neurol 236:122-130
12. Becker NH, Novikoff AB, Zimmerman HM (1967) Fine structure observations of the uptake of intravenously injected peroxidase by the rat choroid plexus. J Histochem Cytochem 15:160-165
13. Bodor N, Buchwald P (2003) Brain targeted drug delivery; experiences to date. Am J Drug Deliv 1:13-26
14. Bundgaard M, Abbott NJ (2008) All vertebrates started out with a glial blood-brain barrier 4-500 million years ago. Glia 56:699-708
15. Caporali A, Emanueli C (2011) MicroRNA regulation in angiogenesis. Vascul Pharmacol 55:79-86
16. Cayrol R, Haqqani AS, Ifergan I, Dodelet-Devillers A, Prat A (2011) Isolation of human brain endothelial cells and characterization of lipid raft-associated proteins by mass spectroscopy. Methods Mol Biol 686:275-295
17. Cording J, Berg J, Käding N, Bellmann C, Tscheik C, Westphal JK, Milatz S, Günzel D, Wolburg H, Piontek J, Huber O, Blasig IE (2013) In tight junctions, claudins regulate the interactions between occludin, tricellulin and marvelD3, which, inversely, modulate claudin oligomerization. J Cell Sci 26:554-564
18. Cristante E, McArthur S, Mauro C, Maggioli E, Romero IA, Wylezinska-Arridge M, Couraud PO, Lopez-Tremoleda J, Christian HC, Weksler BB, Malaspina A, Solito E (2013) Identifi cation of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc Natl Acad Sci U S A 110:832-841
19. Cserr HF, Cooper DN, Suri PK, Patlak CS (1981) Effl ux of radiolabeled polyethylene glycols and albumin from rat brain. Am J Physiol 240:F319-F328
20. Daneman R (2012) The blood-brain barrier in health and disease. Ann Neurol 72:648-672
21. Daneman R, Agalliu D, Zhou L, Kuhnert F, Kuo CJ, Barres BA (2009) Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis. Proc Natl Acad Sci U S A 106:641-646
22. Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468:562-566
23. Dean M, Annilo T (2005) Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Annu Rev Genomics Hum Genet 6:123-142
24. Declèves X, Jacob A, Yousif S, Shawahna R, Potin S, Scherrmann JM (2011) Interplay of drug metabolizing CYP450 enzymes and ABC transporters in the blood-brain barrier. Curr Drug Metab 12:732-741
25. Demel MA, Krämer O, Ettmayer P, Haaksma EE, Ecker GF (2009) Predicting ligand interactions with ABC transporters in ADME. Chem Biodivers 6:1960-1969
26. Dodelet-Devillers A, Cayrol R, van Horssen J, Haqqani AS, de Vries HE, Engelhardt B, Greenwood J, Prat A (2009) Functions of lipid raft membrane microdomains at the blood-brain barrier. J Mol Med (Berl) 87:765-774
27. Dolman D, Drndarski S, Abbott NJ, Rattray M (2005) Induction of aquaporin 1 but not aquaporin 4 messenger RNA in rat primary brain microvessel endothelial cells in culture. J Neurochem 93:825-833
28. Engelhardt B, Coisne C (2011) Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids Barriers CNS 8:4. doi: 10.1186/2045-8118-8-4
29. Fraser PA (2011) The role of free radical generation in increasing cerebrovascular permeability. Free Radic Biol Med 51:967-977
30. Friedman A (2011) Blood-brain barrier dysfunction, status epilepticus, seizures, and epilepsy: a puzzle of a chicken and egg? Epilepsia 52(Suppl 8):19-20
31. Gatlik-Landwojtowicz E, Aänismaa P, Seelig A (2006) Quantifi cation and characterization of P-glycoprotein-substrate interactions. Biochemistry 45:3020-3032
32. Ge S, Song L, Pachter JS (2005) Where is the blood-brain barrier … really? J Neurosci Res 79:421-427
33. Greenwood J, Heasman SJ, Alvarez JI, Prat A, Lyck R, Engelhardt B (2011) Review: Leucocyteendothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol Appl Neurobiol 37:24-39
34. Groothuis DR, Vavra MW, Schlageter KE, Kang EW, Itskovich AC, Hertzler S, Allen CV, Lipton HL (2007) Effl ux of drugs and solutes from brain: the interactive roles of diffusional transcapillary transport, bulk flow and capillary transporters. J Cereb Blood Flow Metab 27:43-56
35. György B, Szabó TG, Pásztói M, Pál Z, Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, Nagy G, Falus A, Buzás EI (2011) Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles. Cell Mol Life Sci 68:2667-2688
36. Hackel D, Krug SM, Sauer RS, Mousa SA, Böcker A, Pfl ücke D, Wrede EJ, Kistner K, Hoffmann T, Niedermirtl B, Sommer C, Bloch L, Huber O, Blasig IE, Amasheh S, Reeh PW, Fromm M, Brack A, Rittner HL (2012) Transient opening of the perineurial barrier for analgesic drug delivery. Proc Natl Acad Sci U S A 109:E2018-E2027
37. Hamel E (2006) Perivascular nerves and the regulation of cerebrovascular tone. J Appl Physiol 100:1059-1064
38. Haqqani AS, Hill JJ, Mullen J, Stanimirovic DB (2011) Methods to study glycoproteins at the blood-brain barrier using mass spectrometry. Methods Mol Biol 686:337-353
39. Haqqani AS, Delaney CE, Tremblay TL, Sodja C, Sandhu JK, Stanimirovic DB (2013) Method for isolation and molecular characterization of extracellular microvesicles released from brain endothelial cells. Fluids Barriers CNS 10:4. doi: 10.1186/2045-8118-10-4
40. Hartmann D, Thum T (2011) MicroRNAs and vascular (dys)function. Vascul Pharmacol 55:92-105
41. Iadecola C, Nedergaard M (2007) Glial regulation of the cerebral microvasculature. Nat Neurosci 10:1369-1376
42. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, Nagelhus EA, Nedergaard M (2012) A paravascular pathway facilitates CSF fl ow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med 4:147ra111. doi: 10.1126/scitranslmed.3003748
43. Janson C, Romanova L, Hansen E, Hubel A, Lam C (2011) Immortalization and functional characterization of rat arachnoid cell lines. Neuroscience 177:23-34
44. Johanson CE, Duncan JA, Klinge PM, Brinker T, Stopa EG, Silverberg GD (2008) Multiplicity of cerebrospinal fl uid functions: new challenges in health and disease. Cerebrospinal Fluid Res 5:10. doi: 10.1186/1743-8454-5-10
45. Kim SY, Buckwalter M, Soreq H, Vezzani A, Kaufer D (2013) Blood-brain barrier dysfunction- induced infl ammatory signaling in brain pathology and epileptogenesis. Epilepsia 53(Suppl 6):37-44
46. Kodaira H, Kusuhara H, Ushiki J, Fuse E, Sugiyama Y (2010) Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, fl avopiridol, and mitoxantrone. J Pharmacol Exp Ther 333:788-796
47. Krämer SD, Schütz YB, Wunderli-Allenspach H, Abbott NJ, Begley DJ (2002) Lipids in blood-brain barrier models in vitro II: infl uence of glial cells on lipid classes and lipid fatty acids. In Vitro Cell Dev Biol 38:566-571
48. Lam CH, Hansen EA, Hubel A (2011) Arachnoid cells on culture plates and collagen scaffolds: phenotype and transport properties. Tissue Eng Part A 17:1759-1766
49. Lam CH, Hansen EA, Janson C, Bryan A, Hubel A (2012) The characterization of arachnoid cell transport II: paracellular transport and blood-cerebrospinal fl uid barrier formation. Neuroscience 222:228-238
50. Liebner S, Corada M, Bangsow T, Babbage J, Taddei A, Czupalla CJ, Reis M, Felici A, Wolburg H, Fruttiger M, Taketo MM, von Melchner H, Plate KH, Gerhardt H, Dejana E (2008) Wnt/beta-catenin signaling controls development of the blood-brain barrier. J Cell Biol 183:409-417
51. Liebner S, Czupalla CJ, Wolburg H (2011) Current concepts of blood-brain barrier development. Int J Dev Biol 55:467-476
52. Liu DZ, Ander BP, Xu H, Shen Y, Kaur P, Deng W, Sharp FR (2010) Blood-brain barrier breakdown and repair by Src after thrombin-induced injury. Ann Neurol 67:526-533
53. MacAulay N, Zeuthen T (2010) Water transport between CNS compartments: contributions of aquaporins and cotransporters. Neuroscience 168:941-956
54. Mäe M, Armulik A, Betsholtz C (2011) Getting to know the cast-cellular interactions and signaling at the neurovascular unit. Curr Pharm Des 17:2750-2754
55. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP (2010) The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 58:1094-1103
56. Mayor S, Pagano RE (2007) Pathways of clathrin-independent endocytosis. Nat Rev Mol Cell Biol 8:603-612
57. McArthur S, Cristante E, Paterno M, Christian H, Roncaroli F, Gillies GE, Solito E (2010) Annexin A1: a central player in the anti-infl ammatory and neuroprotective role of microglia. J Immunol 185:317-328
58. Miller DS (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood brain barrier. Trends Pharmacol Sci 31:246-254
59. Mishra R, Singh SK (2013) HIV-1 Tat C modulates expression of miRNA-101 to suppress VE-cadherin in human brain microvascular endothelial cells. J Neurosci 33:5992-6000
60. Nabeshima S, Reese TS, Landis DMD, Brightman MW (1975) Junctions in the meninges and marginal glia. J Comp Neurol 164:127-169
61. Neuwelt EA, Bauer B, Fahlke C, Fricker G, Iadecola C, Janigro D, Leybaert L, Molnár Z, O’Donnell ME, Povlishock JT, Saunders NR, Sharp F, Stanimirovic D, Watts RJ, Drewes LR (2011) Engaging neuroscience to advance translational research in brain barrier biology. Nat Rev Neurosci 12:169-182
62. Paolinelli R, Corada M, Orsenigo F, Dejana E (2011) The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? Pharmacol Res 63:165-171
63. Parkinson FE, Damaraju VL, Graham K, Yao SY, Baldwin SA, Cass CE, Young JD (2011) Molecular biology of nucleoside transporters and their distributions and functions in the brain. Curr Top Med Chem 11:948-972
64. Patabendige A, Skinner RA, Morgan L, Abbott NJ (2013) A detailed method for preparation of a functional and fl exible blood-brain barrier model using porcine brain endothelial cells. Brain Res 1521:16-30, doi: 10.1016/j.brainres.2013.04.006
65. Potschka H (2012) Role of CNS effl ux drug transporters in antiepileptic drug delivery: overcoming CNS efflux drug transport. Adv Drug Deliv Rev 64:943-952
66. Pottiez G, Duban-Deweer S, Deracinois B, Gosselet F, Camoin L, Hachani J, Couraud PO, Cecchelli R, Dehouck MP, Fenart L, Karamanos Y, Flahaut C (2011) A differential proteomic approach identifies structural and functional components that contribute to the differentiation of brain capillary endothelial cells. J Proteomics 75:628-641
67. Ransohoff RM, Brown MA (2012) Innate immunity in the central nervous system. J Clin Invest 122:1164-1171
68. Ransohoff RM, Engelhardt B (2012) The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol 12:623-635
69. Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119-145
70. Redzic Z (2011) Molecular biology of the blood-brain and the blood-cerebrospinal fl uid barriers: similarities and differences. Fluids Barriers CNS 8:3. doi: 10.1186/2045-8118-8-3
71. Reese TS, Karnovsky MJ (1967) Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 34:207-217
72. Reijerkerk A, Lopez-Ramirez MA, van Het Hof B, Drexhage JA, Kamphuis WW, Kooij G, Vos JB, van der Kraan TC, van Zonneveld AJ, Horrevoets AJ, Prat A, Romero IA, de Vries HE (2013) MicroRNAs regulate human brain endothelial cell-barrier function in infl ammation: implications for Multiple Sclerosis. J Neurosci 33:6857-6863
73. Saijo K, Glass CK (2011) Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol 11:775-787
74. Saunders NR, Daneman R, Dziegielewska KM, Liddelow SA (2013) Transporters of the blood-brain and blood-CSF interfaces in development and in the adult. Mol Aspects Med 34: 742-752
75. Seelig A (2007) The role of size and charge for blood-brain barrier permeation of drugs and fatty acids. J Mol Neurosci 33:32-41
76. Serot JM, Zmudka J, Jouanny P (2012) A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset alzheimer’s disease. J Alzheimers Dis 30:17-26
77. Shawahna R, Uchida Y, Declèves X, Ohtsuki S, Yousif S, Dauchy S, Jacob A, Chassoux F, Daumas-Duport C, Couraud PO, Terasaki T, Scherrmann JM (2011) Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm 8:1332-1341
78. Shen L, Weber CR, Turner JR (2008) The tight junction protein complex undergoes rapid and continuous molecular remodeling at steady state. J Cell Biol 181:683-695
79. Shlosberg D, Benifl a M, Kaufer D, Friedman A (2010) Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 6:393-403
80. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D (2003) Alzheimer’s disease, normalpressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol 2:506-511
81. Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-infl ammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87:10-20
82. Somjen GG (2004) Ions in the brain: normal function, seizures and stroke. Oxford University Press, Oxford
83. Stanimirovic DB, Friedman A (2012) Pathophysiology of the neurovascular unit: disease cause or consequence? J Cereb Blood Flow Metab 32:1207-1221
84. Strazielle N, Ghersi-Egea JF (2013) Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm 10:1473-1491
85. Sykova E, Nicholson C (2008) Diffusion in brain extracellular space. Physiol Rev 88:1277-1340
86. Thorne RG, Nicholson C (2006) In vivo diffusion analysis with quantum dots and dextrans predicts the width of brain extracellular space. Proc Natl Acad Sci U S A 103:5567-5572
87. Tian W, Sawyer A, Kocaoglu FB, Kyriakides TR (2011) Astrocyte-derived thrombospondin-2 is critical for the repair of the blood-brain barrier. Am J Pathol 179:860-868
88. Weerasuriya A, Spangler RA, Rapoport SI, Taylor RE (1984) AC impedance of the perineurium of the frog sciatic nerve. Biophys J 46:167-174
89. Weller RO, Subash M, Preston SD, Mazanti I, Carare RO (2008) Perivascular drainage of amyloidbeta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer’s disease. Brain Pathol 18:253-266
90. Weller RO, Djuanda E, Yow HY, Carare RO (2009) Lymphatic drainage of the brain and the pathophysiology of neurological disease. Acta Neuropathol 117:1-14
91. Wolak DJ, Thorne RG (2013) Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm 10:1492-1504
92. Yang L, Kress BT, Weber HJ, Thiyagarajan M, Wang B, Deane R, Benveniste H, Iliff JJ, Nedergaard M (2013) Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer. J Transl Med 11:107, [Epub ahead of print] PubMed PMID: 23635358
93. Yasuda K, Cline C, Vogel P, Onciu M, Fatima S, Sorrentino BP, Thirumaran RK, Ekins S, Urade Y, Fujimori K, Schuetz EG (2013) Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fl uid barrier. Drug Metab Dispos 41:923-931